SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-015812
Filing Date
2023-09-15
Accepted
2023-09-15 16:05:21
Documents
15
Period of Report
2023-09-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sngx-20230915x8k.htm   iXBRL 8-K 44673
2 EX-16.1 sngx-20230915xex16d1.htm EX-16.1 5422
  Complete submission text file 0001558370-23-015812.txt   268379

Data Files

Seq Description Document Type Size
3 EX-101.SCH sngx-20230915.xsd EX-101.SCH 4052
4 EX-101.DEF sngx-20230915_def.xml EX-101.DEF 3492
5 EX-101.LAB sngx-20230915_lab.xml EX-101.LAB 632
6 EX-101.PRE sngx-20230915_pre.xml EX-101.PRE 10408
9 EXTRACTED XBRL INSTANCE DOCUMENT sngx-20230915x8k_htm.xml XML 4842
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 231258709
SIC: 2834 Pharmaceutical Preparations